624 related articles for article (PubMed ID: 17068149)
1. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
3. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
[TBL] [Abstract][Full Text] [Related]
4. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong Z; Guo J; Glen RC; Morrell NW; Li W
Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
6. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
7. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
[TBL] [Abstract][Full Text] [Related]
8. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
[TBL] [Abstract][Full Text] [Related]
11. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
Kim JH; Peacock MR; George SC; Hughes CC
Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
[TBL] [Abstract][Full Text] [Related]
12. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
13. BMP9 and BMP10: Two close vascular quiescence partners that stand out.
Desroches-Castan A; Tillet E; Bouvard C; Bailly S
Dev Dyn; 2022 Jan; 251(1):178-197. PubMed ID: 34240497
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
Tillet E; Bailly S
Front Genet; 2014; 5():456. PubMed ID: 25620979
[TBL] [Abstract][Full Text] [Related]
16. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
[TBL] [Abstract][Full Text] [Related]
17. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.
Kienast Y; Jucknischke U; Scheiblich S; Thier M; de Wouters M; Haas A; Lehmann C; Brand V; Bernicke D; Honold K; Lorenz S
J Biol Chem; 2016 Feb; 291(7):3395-410. PubMed ID: 26677222
[TBL] [Abstract][Full Text] [Related]
18. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
19. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]